期刊文献+

HepG2细胞中TNFα通过NF-κB信号通路下调GSTA1/GSTA4表达(英文)

Tumor Necrosis Factor Alpha Down-regulated Human GSTA1 and GSTA4 Expression Through The NF-κB Signaling Pathway in Human Hepatoma HepG2 Cells
下载PDF
导出
摘要 谷胱甘肽巯基转移酶α1/α4(GSTA1/A4)是体内重要的解毒酶,可降低多种内、外源性毒性化合物的毒性.然而,胆汁淤积病人肝细胞内G STA1/A4的表达是下调的,下调机制尚不清楚.本研究通过肿瘤坏死因子α(TNFα)处理人肝癌细胞Hep G2细胞,利用实时荧光定量聚合酶链式反应(q PCR)和蛋白质印迹(Western blot)检测GSTA1/A4、核因子κB(NF-κB)和核因子E2相关因子2(Nrf2)的表达.发现TNFα在m RNA水平和蛋白质水平均抑制GSTA1/A4表达,且呈剂量与时间依赖关系.干扰NF-κB信号通路,可减弱T NFα对G STA1/A4表达的抑制作用.以上结果表明,在Hep G2细胞中,TNFα可通过激活N F-κB信号通路抑制G STA1/A4表达. Glutathione S-transferase Alpha1 and Alpha 4(GSTA1 and GSTA4) are crucial for detoxifying a variety of endogenous and exogenous toxic compounds.However,GSTA1/4 expression is reduced in cholestatic patients.The molecular mechanism of GSTA1/4 down-regulation remains elusive.Here,we treated human hepatoma Hep G2 cells with tumor necrosis factor alpha(TNFα)and measured the expression of GSTA1/4,nuclear factor kappa B(NF-κB) and NF-E2 related factor 2(Nrf2) by quantitative real-time quantitative polymerase chain reaction(q PCR) and Western blotting.We found that expression of GSTA1/4 was repressed by TNFα at both the m RNA and the protein level in a dose- and time-dependent manner.Furthermore,inhibiting the NF-κB signaling pathway could attenuate the TNFα induced reduction in GSTA1/4 expression in the Hep G2 cells.Our findings indicate that down-regulation of GSTA1/4 expression in Hep G2 cells is likely triggered by TNFα and mediated by activation of the NF-κB signaling pathway.
出处 《生物化学与生物物理进展》 SCIE CAS CSCD 北大核心 2016年第8期801-809,共9页 Progress In Biochemistry and Biophysics
基金 supported by grants from The National Natural Science Foundation of China(81370560,81570576,81470850,81470880)~~
关键词 GSTA1/GSTA4 TNFΑ NF-ΚB 胆汁淤积 GSTA1/GSTA4 TNFα NF-κB cholestasis
  • 相关文献

参考文献50

  • 1Hirschfield G M, Heathcote E J, Gershwin M E. Pathogenesis of cholestatic liver disease and therapeutic approaches. Gastroenterology , 2010, 139 (5) : 1481-1496 DOI:10.1053/j.gastro.2010.09.004.
  • 2Erlinger S. What is cholestasis in 1985. Journal of Hepatology , 1985, 1 (6) : 687-693 DOI:10.1016/S0168-8278(85)80012-X.
  • 3Paumgartner G. Medical treatment of cholestatic liver diseases: From pathobiology to pharmacological targets. World Journal of Gastroenterology: WJG , 2006, 12 (28) : 4445-4451 DOI:10.3748/wjg.v12.i28.4445.
  • 4Zollner G, Trauner M. Mechanisms of cholestasis. Clinics in Liver Disease , 2008, 12 (1) : 1-26 DOI:10.1016/j.cld.2007.11.010.
  • 5Kasahara E, Miyoshi M, Konaka R, et al. Role of oxidative stress in germ cell apoptosis induced by di (2-ethylhexyl) phthalate. Biochemical Journal , 2002, 365 (3) : 849-856 DOI:10.1042/bj20020254.
  • 6Perez M J, Macias R I R, Duran C, et al. xidative stress and apoptosis in fetal rat liver induced by maternal cholestasis. Protective effect of ursodeoxycholic acid. Journal of Hepatology , 2005, 43 (2) : 324-332.
  • 7Boyer J L. Nuclear receptor ligands: rational and effective therapy for chronic cholestatic liver disease. Gastroenterology , 2005, 129 (2) : 735-740 DOI:10.1016/j.gastro.2005.06.053.
  • 8Montilla P, Cruz A, Padillo F J, et al. Melatonin versus vitamin E as protective treatment against oxidative stress after extra-hepatic bile duct ligation in rats. Journal of Pineal Research , 2001, 31 (2) : 138-144 DOI:10.1111/jpi.2001.31.issue-2.
  • 9Ozturk H, Eken H, Ozturk H, et al. Effects of dexamethasone on small bowel and kidney oxidative stress and histological alterations in bile duct-ligated rats. Pediatric Surgery International , 2006, 22 (9) : 709-718 DOI:10.1007/s00383-006-1736-2.
  • 10Tokac M, Taner G, Aydin S, et al. Protective effects of curcumin against oxidative stress parameters and DNA damage in the livers and kidneys of rats with biliary obstruction. Food and Chemical Toxicology , 2013, 61 (11) : 28-35.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部